These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4103929

  • 21. The diagnosis and management of thyrotoxicosis associated with Graves' disease.
    Mazzaferri EL.
    Med Times; 1972 Aug; 100(8):47-61 passim. PubMed ID: 4114172
    [No Abstract] [Full Text] [Related]

  • 22. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Aug; 58(1):248-53. PubMed ID: 15314994
    [Abstract] [Full Text] [Related]

  • 23. [Medical treatment and therapeutic indications in hyperthyroidism].
    Vague J.
    Cah Med; 1972 Dec 30; 13(17):1257-62. PubMed ID: 4121376
    [No Abstract] [Full Text] [Related]

  • 24. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
    Nagataki S, Uchimura H, Ikeda H, Matsuzaki F, Imai Y.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):409. PubMed ID: 4141671
    [No Abstract] [Full Text] [Related]

  • 25. [Basedow's disease with malignant exophthalmos treated with radioactive total thyroidectomy].
    Stancu H, Bălan M.
    Stud Cercet Endocrinol; 1973 Feb 20; 24(3):231-3. PubMed ID: 4739974
    [No Abstract] [Full Text] [Related]

  • 26. [Therapy of Basedow's disease].
    Burger AG.
    Schweiz Rundsch Med Prax; 1988 Feb 16; 77(7):143-5. PubMed ID: 2451854
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
    Ikeda H, Imai Y, Uchimura H, Matsuzaki F, Nagataki S.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):408. PubMed ID: 4141670
    [No Abstract] [Full Text] [Related]

  • 30. Surgery for Graves' disease.
    Black BM.
    Mayo Clin Proc; 1972 Dec 20; 47(12):966-8. PubMed ID: 4117992
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [The pharmacological therapy of Basedow's disease].
    Lazzarin M, Segattini L, Benati F.
    Recenti Prog Med; 1993 Oct 20; 84(10):698-708. PubMed ID: 7694335
    [Abstract] [Full Text] [Related]

  • 33. [Contemporary treatment of diffuse toxic goiter].
    Spesivtseva VG, Liashko KIa.
    Sov Med; 1970 Oct 20; 33(8):103-11. PubMed ID: 4099132
    [No Abstract] [Full Text] [Related]

  • 34. [Basedow's disease].
    Scheidegger K.
    Schweiz Rundsch Med Prax; 1993 Aug 10; 82(32):840-4. PubMed ID: 7690495
    [Abstract] [Full Text] [Related]

  • 35. [Development of agranulocytosis by the administration of an antithyroid drug, Mercazole, followed by a successful surgical treatment combined with administration of inorganic iodine and propranolol in a case of Basedow's disease].
    Kanaoka M, Gozen T, Iida Y, Endo K, Konishi J.
    Horumon To Rinsho; 1983 Jan 10; 31(1):51-4. PubMed ID: 6189651
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.